B. R. Stultz1, D. Milia1, T. Carver1, C. Dodgion1 1Medical College Of Wisconsin,Milwaukee, WI, USA
Introduction: Forty percent of trauma related in-hospital deaths involve massive hemorrhage. Recent studies have demonstrated that high ratio massive transfusions are related to improved outcomes but this has not been evaluated in a national cohort. The purpose of this study was to use the Trauma Quality Improvement Program (TQIP) database to determine the adoption and efficacy of high ratio transfusions.
Methods: A retrospective analysis of adult massive transfusions from 2013-2015 within the TQIP database was performed. Massive transfusions were defined as ≥4 and ≥10 units of packed red blood cells (PRBC) at 4 and 24 hours, respectively. High ratio transfusion (HRT) was defined as plasma:platelets:pRBC ≥1:1:2. Multivariate logistic regression was used to evaluate morbidity and mortality of patients receiving HRT with ratios of ≥1:1:1 and ≥1:1:2. Rate of adoption of HRT transfusion was evaluated by year.
Results: 20,009/689,072 (2.8%) patients underwent a massive transfusion in 318 level I & II trauma centers. The median age was 38 with median injury severity scores of 26. Seventy-six percent were male and median LOS was 11 days. Thirty-three percent suffered penetrating injuries, 61% underwent operative intervention and 44% underwent HRT. Overall mortality rate was 31%. Ratios of ≥1:1:1 decreased mortality (OR 0.88, p=0.012), with significant improvement if met at 4 hours (OR 0.61, p<0.01). ≥1:1:2 decreased mortality at 24 hours (OR 0.71, p<.0001) but not 4h. Those with HRT had increased risk for complications (OR 1.5, p<.0001). In 2015, patients were significantly more likely (OR 1.2 p≤.0001) to receive HRTs when compared to previous years.
Conclusion: Adoption of HRT is significantly increasing overtime with early ratios of 1:1:1 or better conferring the greatest mortality benefit. However, there remain opportunities for significant improvement since more than half of the patients did not reach the high ratio transfusion threshold.